Back to Search Start Over

Pleiotropic Effects of GIP on Islet Function Involves Osteopontin

Authors :
Marco Bugliani
Emma Ahlqvist
Piero Marchetti
Ola Hansson
Timothy J. Kieffer
Emily Sonestedt
Yang De Marinis
Alena Stančáková
Kasper Pilgaard
Nils Wierup
Stefano DelPrato
Sara Bonetti
Markku Laakso
Olga Kotova
Charlotte Brøns
Roberto Miccoli
Valeriya Lyssenko
Peter M. Nilsson
Pontus Dunér
Peter Osmark
Tiinamaija Tuomi
Albert Salehi
Pernille Poulsen
Sten Madsbad
Allan Vaag
Lisa Berglund
Alexander Balhuizen
Richa Saxena
Olle Melander
Johanna Kuusisto
Anna Wendt
Leif Groop
Marju Orho-Melander
Anna Jonsson
Maria F. Gomez
Jalal Taneera
Bo Isomaa
Riccardo C. Bonadonna
Lena Eliasson
Source :
Diabetes; Vol 60, Diabetes
Publication Year :
2011

Abstract

OBJECTIVE The incretin hormone GIP (glucose-dependent insulinotropic polypeptide) promotes pancreatic β-cell function by potentiating insulin secretion and β-cell proliferation. Recently, a combined analysis of several genome-wide association studies (Meta-analysis of Glucose and Insulin-Related Traits Consortium [MAGIC]) showed association to postprandial insulin at the GIP receptor (GIPR) locus. Here we explored mechanisms that could explain the protective effects of GIP on islet function. RESEARCH DESIGN AND METHODS Associations of GIPR rs10423928 with metabolic and anthropometric phenotypes in both nondiabetic (N = 53,730) and type 2 diabetic individuals (N = 2,731) were explored by combining data from 11 studies. Insulin secretion was measured both in vivo in nondiabetic subjects and in vitro in islets from cadaver donors. Insulin secretion was also measured in response to exogenous GIP. The in vitro measurements included protein and gene expression as well as measurements of β-cell viability and proliferation. RESULTS The A allele of GIPR rs10423928 was associated with impaired glucose- and GIP-stimulated insulin secretion and a decrease in BMI, lean body mass, and waist circumference. The decrease in BMI almost completely neutralized the effect of impaired insulin secretion on risk of type 2 diabetes. Expression of GIPR mRNA was decreased in human islets from carriers of the A allele or patients with type 2 diabetes. GIP stimulated osteopontin (OPN) mRNA and protein expression. OPN expression was lower in carriers of the A allele. Both GIP and OPN prevented cytokine-induced reduction in cell viability (apoptosis). In addition, OPN stimulated cell proliferation in insulin-secreting cells. CONCLUSIONS These findings support β-cell proliferative and antiapoptotic roles for GIP in addition to its action as an incretin hormone. Identification of a link between GIP and OPN may shed new light on the role of GIP in preservation of functional β-cell mass in humans.

Details

Language :
English
Database :
OpenAIRE
Journal :
Diabetes; Vol 60, Diabetes
Accession number :
edsair.doi.dedup.....cdf4910e13f36b924b3c6cfde6bced02